Arena Pharmaceuticals is Drug Discovery in United States that focus on South Korea business. Founded in 1997. They cover business area such as Arena Pharmaceuticals, G-protein-couple receptor, one internally discover drug, lorcaserin, South Korea, weight management, Belviq, Eisai, a presence, Europe, its swiss subsidiary, autoimmune disease, vascular disease, thrombotic disease, dementia-associate psychosis, nervous system issue, pain.
1997
( 27 years old in 2024 )
South Korea
-
6154 Nancy Ridge Drive
San Diego, CA 92121
United States
Private
Arena PharmaceuticalsG-protein-couple receptorone internally discover druglorcaserinSouth Koreaweight managementBelviqEisaia presenceEuropeits swiss subsidiaryautoimmune diseasevascular diseasethrombotic diseasedementia-associate psychosisnervous system issuepain
* We use standard office opening hours in near Arena Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Arena Pharmaceuticals is Drug Discovery business from United States that founded in 1997 (27 years old in 2024), Arena Pharmaceuticals business is focusing on South Korea.
Arena Pharmaceuticals headquarter office and corporate office address is located in 6154 Nancy Ridge Drive San Diego, CA 92121 United States.
Arena Pharmaceuticals was founded in United States.
In 2024, Arena Pharmaceuticals is currently focus on South Korea sector.
Above is snippet of Google Trends for "South Korea" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Arena Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
